Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds

Gynecologic Oncology

Volumn 78, Issue 3 I, 2000, Pages 278-287

  Casey, Murray Joseph ^a   Bewtra, Chhanda ^a   Hoehne, Laura L ^a   Tatpati, Abraham D ^a   Lynch, Henry T ^a   Watson, Patrice ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Ovarian histology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; DATA BASE; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MICROSCOPY; OVARIECTOMY; OVARY CANCER; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0033818160     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5861     Document Type: Article

References (31)

1. Pathology of early malignant change in the ovary
2. Ovarian dysplasia. A study of identical twins
3. Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma
4. Contralateral ovary in unilateral ovarian carcinoma: A search for preneoplastic lesions
5. Morphologic precursors of ovarian epithelial tumors
6. Familial association of breast/ovarian carcinoma
7. Breast cancer family history as a risk factor for early onset breast cancer
8. Hereditary ovarian cancer, pedigree studies, part II
9. Hereditary ovarian cancer: Heterogeneity in age at diagnosis
10. Linkage of early-onset familial breast cancer to chromosome 17q21
11. Familial breast-ovarian cancer locus on chromosome 17q12-q23
12. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
13. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
14. Identification of the breast cancer susceptibility gene BRCA2
15. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
16. Breast and ovarian cancer incidence in BRCA1 mutation carriers. The Breast Cancer Linkage Consortium
17. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
18. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
19. Hereditary ovarian cancer: A clinicopathologic study
20. Benign ovarian surface epithelium in BRCA1 positive women
21. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies
22. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer
23. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families
24. Characteristics of familial ovarian cancer: A report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry
25. Clinical and pathological features of ovarian cancer in women with germline mutations of BRCA1
26. Ovarian dysplasia in prophylactic oophorectomy specimens. Cytogenetic and morphometric correlations
27. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group
28. Surface Epithelial-Stromal Tumors of the Ovary
29. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors
30. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer
31. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome